Perform Another (Advanced) Search

1.  CenterWatch: Clinical Trials in Category (179) HIV Infections
...Hobson City : Research Site: A Study Comparing the Efficacy and Safety of Once-Daily Fuzeon (Enfuvirtide) Dosing Versus the Currently Recommended Twice-Daily Dosing in Human Immunodeficiency Virus-Type 1 (HIV ...
...Patients With HIV-1 Infection Arizona Phoenix : Research Site: AMICI Study: A Study of Fuzeon (Enfuvirtide) With an Integrase Inhibitor Plus Optimized Background in Treatment-Experienced HIV-1 Infected Patients. Phoenix ...
View Page

2. Advanced/Specific Search Results Fuzeon [enfuvirtide]
...Advanced/Specific Search Results Fuzeon [enfuvirtide] Clinical Trial Results: Fuzeon [enfuvirtide] Product Name: Fuzeon [enfuvirtide] Date of Report: 9/19/2001 Phase: II A Controlled Phase ...
View Page

3. Clinical Trial Results: HIV Infections
...Clinical Trial Results: HIV Infections Clinical Trial Results: HIV Infections Product Name: Fuzeon [enfuvirtide] Date of Report: 9/19/2001 Phase: II A Controlled Phase II Trial Assessing 3 ...
...in Combination with Abacavir, Amprenavir, Ritonavir, and Efavirenz in HIV-Infected Adults Product Name: Fuzeon [enfuvirtide] Date of Report: 10/8/2001 Phase: II A Phase II Rollover Protocol for HIV ...
View Page

4. Clinical Trial Results by Drug Names
...efficacy and safety of an optimised background antiretroviral regimen (OB) compared to OB associated with enfuvirtide in previously treated HIV-1 infected patients in virological success after a 28-week induction treatment with enfuvirtide plus OB (The INDEED Study) Fast Facts: Protocol number: ML18242 Sponsor: Roche SAS Company division ...
View Page

5.  Newly Approved Drug Therapies (823) Fuzeon (enfuvirtide), Trimeris, Roche,
...Newly Approved Drug Therapies (823) Fuzeon (enfuvirtide), Trimeris, Roche, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Fuzeon (enfuvirtide) Company: Trimeris, Roche Approval Status: Approved March 2003 Treatment Area: HIV Infection General Information Fuzeon ...
View Page

6. Clinical Trial Results by Drug Names
...Drug Names Clinical Trial Result Information Title of Study: Single-dose study of pharmacokinetics of enfuvirtide (FUZEON, T20/RO29-9800) in HIV-1 infected subjects with renal impairment. Fast Facts: Protocol ...
...number: NP17586 Sponsor: Hoffmann-La Roche Ltd. Company division: Pharmaceutical Product name: Fuzeon Generic name: enfuvirtide Phase of development: IV Therapeutic area, approved indication: HIV Infections Date of report: 6/1 ...
View Page

7. Clinical Trial Results by Drug Names
...of Study: Evaluation of the viral burden decrease rate in HIV naïve patients treated with enfuvirtide, in comparison to the standard therapy Fast Facts: Protocol number: ML18243 Sponsor: Roche S.p.A. Italy Company division: Pharmaceutical Product name: Fuzeon Generic name: enfuvirtide Phase of development: II Therapeutic area, approved indication: HIV infection Date of report: 1/30 ...
View Page

8. Clinical Trial Results by Drug Names
...Names Clinical Trial Result Information Title of Study: Multicenter open-label early access program of Enfuvirtide (T-20, HIV-1 Fusion Inhibitor) in combination with free choice antiviral regimen in patients ...
...MV16721 Sponsor: F. Hoffmann-La Roche Ltd. Company division: Pharmaceutical Product name: Fuzeon Generic name: enfuvirtide Phase of development: IV Therapeutic area, approved indication: HIV Infections Date of report: 1/1 ...
View Page

9. Clinical Trial Results by Drug Names
...Results by Drug Names Clinical Trial Result Information Title of Study: A Study of Fuzeon (Enfuvirtide) in Patients With Advanced HIV Infection. Fast Facts: Protocol number: ML17819 Sponsor: F. Hoffmann-La Roche Ltd Company division: Pharmaceutical Product name: Fuzeon Generic name: enfuvirtide Phase of development: IV Therapeutic area, approved indication: HIV Infections Date of report: To be ...
View Page

10. Clinical Trial Results by Drug Names
...Clinical Trial Result Information Title of Study: A phase III, open-label, safety study of enfuvirtide (HIV-1 fusion inhibitor) in combination with oral antiretrovirals in patients who are unable to ...
...T20-305) Sponsor: Hoffmann-La Roche Inc. Company division: Pharmaceutical Product name: Fuzeon Generic name: enfuvirtide Phase of development: III Therapeutic area, approved indication: HIV Infections Date of report: 11/1 ...
View Page

11. Clinical Trial Results by Drug Names
...cohort study to assess HIV-1 patient QUAlity of LIfe and Tolerability after administration of Enfuvirtide-containing HAART (QUALITE study). Fast Facts: Protocol number: ML18018 Sponsor: Roche Laboratories Inc. Company division: Pharmaceutical Product name: Fuzeon Generic name: enfuvirtide Phase of development: IV Therapeutic area, approved indication: HIV infection Date of report: 3/1 ...
View Page

12.  Study Posting (4519) Trial #96133, HIV Infections, Houston, TX
...Houston, TX Trial Information A Study Comparing the Efficacy and Safety of Once-Daily Fuzeon (Enfuvirtide) Dosing Versus the Currently Recommended Twice-Daily Dosing in Human Immunodeficiency Virus-Type 1 (HIV ...
...II open-label, randomized, active-controlled study comparing the efficacy and safety of once daily enfuvirtide dosing versus the currently recommended twice daily dosing in HIV-1 infected treatment-experienced patients ...
View Page

13.  Study Posting (4519) Trial #98527, HIV Infections, Austin, TX
...Austin, TX Trial Information A Study Comparing the Efficacy and Safety of Once-Daily Fuzeon (Enfuvirtide) Dosing Versus the Currently Recommended Twice-Daily Dosing in Human Immunodeficiency Virus-Type 1 (HIV ...
...II open-label, randomized, active-controlled study comparing the efficacy and safety of once daily enfuvirtide dosing versus the currently recommended twice daily dosing in HIV-1 infected treatment-experienced patients ...
View Page

14.  Study Posting (4519) Trial #100358, HIV Infections, Philadelphia, PA
...Philadelphia, PA Trial Information A Study Comparing the Efficacy and Safety of Once-Daily Fuzeon (Enfuvirtide) Dosing Versus the Currently Recommended Twice-Daily Dosing in Human Immunodeficiency Virus-Type 1 (HIV ...
...II open-label, randomized, active-controlled study comparing the efficacy and safety of once daily enfuvirtide dosing versus the currently recommended twice daily dosing in HIV-1 infected treatment-experienced patients ...
View Page

15.  Study Posting (4519) Trial #98518, HIV Infections, Allentown, PA
...Allentown, PA Trial Information A Study Comparing the Efficacy and Safety of Once-Daily Fuzeon (Enfuvirtide) Dosing Versus the Currently Recommended Twice-Daily Dosing in Human Immunodeficiency Virus-Type 1 (HIV ...
...II open-label, randomized, active-controlled study comparing the efficacy and safety of once daily enfuvirtide dosing versus the currently recommended twice daily dosing in HIV-1 infected treatment-experienced patients ...
View Page

16.  Study Posting (4519) Trial #102408, HIV Infections, Union , NJ
...Union , NJ Trial Information A Study Comparing the Efficacy and Safety of Once-Daily Fuzeon (Enfuvirtide) Dosing Versus the Currently Recommended Twice-Daily Dosing in Human Immunodeficiency Virus-Type 1 (HIV ...
...II open-label, randomized, active-controlled study comparing the efficacy and safety of once daily enfuvirtide dosing versus the currently recommended twice daily dosing in HIV-1 infected treatment-experienced patients ...
View Page

17.  Study Posting (4519) Trial #98616, HIV Infections, Detroit, MI
...Detroit, MI Trial Information A Study Comparing the Efficacy and Safety of Once-Daily Fuzeon (Enfuvirtide) Dosing Versus the Currently Recommended Twice-Daily Dosing in Human Immunodeficiency Virus-Type 1 (HIV ...
...II open-label, randomized, active-controlled study comparing the efficacy and safety of once daily enfuvirtide dosing versus the currently recommended twice daily dosing in HIV-1 infected treatment-experienced patients ...
View Page

18.  Study Posting (4519) Trial #96109, HIV Infections, Boston, MA
...Boston, MA Trial Information A Study Comparing the Efficacy and Safety of Once-Daily Fuzeon (Enfuvirtide) Dosing Versus the Currently Recommended Twice-Daily Dosing in Human Immunodeficiency Virus-Type 1 (HIV ...
...II open-label, randomized, active-controlled study comparing the efficacy and safety of once daily enfuvirtide dosing versus the currently recommended twice daily dosing in HIV-1 infected treatment-experienced patients ...
View Page

19.  Study Posting (4519) Trial #102400, HIV Infections, Sarasota , FL
...Sarasota , FL Trial Information A Study Comparing the Efficacy and Safety of Once-Daily Fuzeon (Enfuvirtide) Dosing Versus the Currently Recommended Twice-Daily Dosing in Human Immunodeficiency Virus-Type 1 (HIV ...
...II open-label, randomized, active-controlled study comparing the efficacy and safety of once daily enfuvirtide dosing versus the currently recommended twice daily dosing in HIV-1 infected treatment-experienced patients ...
View Page

20.  Study Posting (4519) Trial #100592, HIV Infections, Miami, FL
...Miami, FL Trial Information A Study Comparing the Efficacy and Safety of Once-Daily Fuzeon (Enfuvirtide) Dosing Versus the Currently Recommended Twice-Daily Dosing in Human Immunodeficiency Virus-Type 1 (HIV ...
...II open-label, randomized, active-controlled study comparing the efficacy and safety of once daily enfuvirtide dosing versus the currently recommended twice daily dosing in HIV-1 infected treatment-experienced patients ...
View Page